Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 8521 AL 8535

A novel homozygous mutation of GJC2 derived from maternal uniparental disomy in a female patient with Pelizaeus-Merzbacher-like disease

Shimojima K, Tanaka R, Shimada S, Sangu N, Nakayama J, Iwasaki N, Yamamoto T.

J Neurol Sci. 2013 Jul 15;330(1-2):123-6. doi: 10.1016/j.jns.2013.04.017. Epub 2013 May 16.

A nervous predisposition to unrepaired DNA double strand breaks

Reynolds JJ, Stewart GS.

DNA Repair (Amst). 2013 Aug;12(8):588-99. doi: 10.1016/j.dnarep.2013.04.011. Epub 2013 May 17.

DNA repair mechanisms in dividing and non-dividing cells

Iyama T, Wilson DM 3rd.

DNA Repair (Amst). 2013 Aug;12(8):620-36. doi: 10.1016/j.dnarep.2013.04.015. Epub 2013 May 16.

Phenotypes of hypofrontality in older female fragile X premutation carriers

Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM.

Ann Neurol. 2013 Aug;74(2):275-83. doi: 10.1002/ana.23933.

Brown-Vialetto-Van Laere syndrome: clinical and neuropathologic findings with immunohistochemistry for C20orf54 in three affected patients

Malafronte P, Clark HB, Castaneda-Sanchez I, Raisanen J, Hatanpaa KJ.

Pediatr Dev Pathol. 2013 Sep-Oct;16(5):364-71. doi: 10.2350/13-02-1299-CR.1. Epub 2013 May 20.

[Unilateral optic neuritis and Miller Fisher syndrome]

Tabary A, Lousteau B, Signolles C.

J Fr Ophtalmol. 2013 Jun;36(6):e93-9. doi: 10.1016/j.jfo.2012.09.011. Epub 2013 May 17.

MRI findings in a rottweiler with leukoencephalomyelopathy

Eagleson JS, Kent M, Platt SR, Rech RR, Howerth EW.

J Am Anim Hosp Assoc. 2013 Jul-Aug;49(4):255-61. doi: 10.5326/JAAHA-MS-5864. Epub 2013 May 20.

Intranuclear inclusions in a fragile X mosaic male

Pretto DI, Hunsaker MR, Cunningham CL, Greco CM, Hagerman RJ, Noctor SC, Hall DA, Hagerman PJ, Tassone F.

Transl Neurodegener. 2013 May 21;2(1):10. doi: 10.1186/2047-9158-2-10.

[Infectious properties of protein aggregates involved in neurodegenerative diseases]

Bousset L, Melki R.

Biol Aujourdhui. 2013;207(1):55-9. doi: 10.1051/jbio/2013004. Epub 2013 May 23.

Neurodegenerative disorders and metabolic disease

Pierre G.

Arch Dis Child. 2013 Aug;98(8):618-24. doi: 10.1136/archdischild-2012-302840. Epub 2013 May 22.

Clinical application of whole-exome sequencing: a novel autosomal recessive spastic ataxia of Charlevoix-Saguenay sequence variation in a child with ataxia

Liew WK, Ben-Omran T, Darras BT, Prabhu SP, De Vivo DC, Vatta M, Yang Y, Eng CM, Chung WK.

JAMA Neurol. 2013 Jun;70(6):788-91. doi: 10.1001/jamaneurol.2013.247.

A novel OPA3 mutation revealed by exome sequencing: an example of reverse phenotyping

Arif B, Kumar KR, Seibler P, Vulinovic F, Fatima A, Winkler S, Nürnberg G, Thiele H, Nürnberg P, Jamil AZ, Brüggemann A, Abbas G, Klein C, Naz S, Lohmann K.

JAMA Neurol. 2013 Jun;70(6):783-7. doi: 10.1001/jamaneurol.2013.1174.

New subtype of spinocerebellar ataxia with altered vertical eye movements mapping to chromosome 1p32

Serrano-Munuera C, Corral-Juan M, Stevanin G, San Nicolás H, Roig C, Corral J, Campos B, de Jorge L, Morcillo-Suárez C, Navarro A, Forlani S, Durr A, Kulisevsky J, Brice A, Sánchez I, Volpini V, Matilla-Dueñas A.

JAMA Neurol. 2013 Jun;70(6):764-71. doi: 10.1001/jamaneurol.2013.2311.

Progressive multifocal leukoencephalopathy (PML) associated with HIV Clade C--is not uncommon

Netravathi M, Mahadevan A, Satishchandra P, Shobha N, Mailankody P, Kandavel T, Jitender S, Anantaram G, Nagarathna S, Govekar S, Ravikumar BV, Ravi V, Shankar SK.

J Neurovirol. 2013 Jun;19(3):198-208. doi: 10.1007/s13365-013-0168-8. Epub 2013 May 23.

A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)

Gupta P, Mulkey F, Hasserjian RP, Sanford BL, Vij R, Hurd DD, Odenike OM, Bloomfield CD, Owzar K, Stone RM, Larson RA; Alliance for Clinical Trials in Oncology.

Invest New Drugs. 2013 Oct;31(5):1311-20. doi: 10.1007/s10637-013-9978-z. Epub 2013 May 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias